Reduced platelet aggregation after fluvastatin therapy is associated with altered platelet lipid composition and drug binding to the platelets.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  British Journal of Clinical Pharmacology

• Publication date

  2003-10-02

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1046/J.1365-2125.1997.00625.XPMID 9241100PMCID PMC2042800
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reduced susceptibility of low density lipoprotein (LDL) to lipid peroxidation after fluvastatin therapy is associated with the hypocholesterolemic effect of the drug and its binding to the LDL.

  1997cited by this paper
• LDL-Platelet Interaction Under Oxidative Stress Induces Macrophage Foam Cell Formation

  1995cited by this paper
• Hyperlipidemia and coronary disease. Correction of the increased thrombogenic potential with cholesterol reduction.

  1995cited by this paper
• Lovastatin decreases plasma and platelet cholesterol levels and normalizes elevated platelet fluidity and aggregation in hypercholesterolemic patients.

  1994cited by this paper
• Comparison of properties of four inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.

  1994cited by this paper
• Pravastatin inhibits cellular cholesterol synthesis and increases low density lipoprotein receptor activity in macrophages: in vitro and in vivo studies.

  1994cited by this paper
• Influences of lipid-modifying agents on hemostasis

  1993cited by this paper
• Decreased sensitivity to adenosine in platelets from patients with familial hypercholesterolaemia—a change reversed by cholestyramine treatment

  1993cited by this paper
• The actions of lovastatin on platelet function and platelet eicosanoid receptors in type II hypercholesterolaemia

  1993cited by this paper
• A Quarter Century of Drug Treatment of Dyslipoproteinemia, With a Focus on the New HMG‐CoA Reductase Inhibitor Fluvastatin

  1993cited by this paper
• The influence of lipoproteins on blood platelets.

  1993cited by this paper
• Platelets and the arterial wall lesion

  1992cited by this paper
• Lovastatin inhibits low-density lipoprotein oxidation and alters its fluidity and uptake by macrophages: in vitro and in vivo studies.

  1992cited by this paper
• Pharmacokinetics of Fluvastatin After Single and Multiple Doses in Normal Volunteers

  1992cited by this paper
• Activated platelets secrete a protein-like factor that stimulates oxidized-LDL receptor activity in macrophages.

  1991cited by this paper
• Effect of Lipoproteins and Platelets on Macrophage Cholesterol Metabolism

  1991cited by this paper
• Secretory products from human monocyte-derived macrophages enhance platelet aggregation.

  1991cited by this paper
• Dual Effect of Lovastatin and Simvastatin on LDL-Macrophage Interaction

  1991cited by this paper
• Reduction of LDL cholesterol by pravastatin does not influence platelet activation in patients with mild hypercholesterolaemia at risk of coronary heart disease.

  1991cited by this paper
• Comparative Pharmacokinetics and Pharmacodynamics of Pravastatin and Lovastatin

  1990cited by this paper
• Role of platelet secretory products in modified lipoprotein metabolism in macrophages.

  1989cited by this paper
• Platelet activation by oxidatively modified low density lipoproteins.

  1989cited by this paper
• Platelet secretory products enhance LDL receptor activity and inhibit scavenger receptor activity in human monocyte derived macrophages.

  1989cited by this paper
• HMG-CoA reductase inhibitors for treatment of hypercholesterolemia.

  1988cited by this paper
• Role of platelets in cholesteryl ester formation by U-937 cells.

  1988cited by this paper
• Angiogenic factors.

  1987cited by this paper
• New mechanism for foam cell generation in atherosclerotic lesions.

  1987cited by this paper
• The pathogenesis of atherosclerosis--an update.

  1986cited by this paper
• Role of Platelets in Atherosclerosis

  1986cited by this paper
• The role of platelets in the development and complications of atherosclerosis.

  1986cited by this paper
• Platelet low-density lipoprotein receptors

  1985cited by this paper
• Abnormal plasma lipoprotein composition in hypercholesterolaemic patients induces platelet activation

  1984cited by this paper
• Native and modified low-density-lipoprotein interaction with human platelets in normal and homozygous familial-hypercholesterolaemic subjects.

  1984cited by this paper
• Platelet function and lipoprotein levels after plasma-exchange in patients with familial hypercholesterolaemia.

  1983cited by this paper
• Platelet interaction with high and low density lipoproteins.

  1983cited by this paper
• The effect of human plasma on platelet function in familial hypercholesterolemia.

  1982cited by this paper
• Platelet function and platelet lipid composition in the dyslipoproteinemias.

  1980cited by this paper
• Platelet-derived growth factor stimulates activity of low density lipoprotein receptors.

  1980cited by this paper
• The low-density lipoprotein pathway and its relation to atherosclerosis.

  1977cited by this paper
• Two dimensional then layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots.

  1970cited by this paper
• Study of the ferric chloride method for determination of total cholesterol and cholesterol esters.

  1959cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Effect of lipid-lowering therapy on platelet reactivity in patients treated with and without antiplatelet therapy.

  2023cites this paper
• Platelet Membrane: An Outstanding Factor in Cancer Metastasis

  2022cites this paper
• Influence of Antiplatelet Agents on the Lipid Composition of Platelet Plasma Membrane: A Lipidomics Approach with Ticagrelor and Its Active Metabolite

  2021cites this paper
• Hypercholesterolemia impairs the Glucagon-like peptide 1 action on platelets: Effects of a lipid-lowering treatment with simvastatin.

  2019cites this paper
• Simvastatin Effects on Inflammation and Platelet Activation Markers in Hypercholesterolemia

  2018cites this paper
• Fluvastatin for lowering lipids.

  2018cites this paper
• Acetylsalicylic acid differentially limits the activation and expression of cell death markers in human platelets exposed to Staphylococcus aureus strains

  2017cites this paper
• Lipid-lowering efficacy of rosuvastatin.

  2017cites this paper
• Non-alcoholic fatty liver disease and liver transplantation.

  2016cites this paper
• Lovastatin induces platelet apoptosis.

  2016cites this paper
• Effects of peroxisome proliferator-activated receptor γ in simvastatin antiplatelet activity: influences on cAMP and mitogen-activated protein kinases.

  2014cites this paper
• Can a High Reloading Dose of Atorvastatin Prior to Percutaneous Coronary Intervention Reduce Periprocedural Myocardial Infarction?

  2014cites this paper
• Antithrombotic actions of statins involve PECAM-1 signaling.

  2013cites this paper
• Reduction of platelet cytosolic phospholipase A2 activity by atorvastatin and simvastatin: biochemical regulatory mechanisms.

  2013cites this paper
• Effect of red mold rice on blood coagulation and anticoagulation factors in a rat model of hyperlipidemia

  2013cites this paper
• Effect of Atorvastatin on Hematologic Parameters in Patients With Hypercholesterolemia

  2013cites this paper
• INDIGENOUS HERBAL PRODUCT NIGELLA SATIVA PROVED EFFECTIVE AS AN ANTIHYPERTENSIVE IN METABOLIC SYNDROME

  2013cites this paper
• Arterial elasticity in obese subjects with coronary slow flow phenomenon.

  2013cites this paper
• Cholesterol enrichment of rabbit platelets enhances the Ca(2+) entry pathway induced by platelet-derived secondary feedback agonists.

  2013cites this paper
• THERAPEUTIC EFFECT OF NIGELLA SATIVA IN PATIENTS OF POOR GLYCEMIC CONTROL

  2012cites this paper
• Pravastatin and simvastatin improves acetylsalicylic acid‐mediated in vitro blood platelet inhibition

  2012cites this paper
• Drugs that Affect Platelet Function

  2012cites this paper
• Contribution of the P2Y12 receptor‐mediated pathway to platelet hyperreactivity in hypercholesterolemia

  2011cites this paper
• The proton gradient of secretory granules and glutamate transport in blood platelets during cholesterol depletion of the plasma membrane by methyl-β-cyclodextrin.

  2011cites this paper
• Statins have an early antiplatelet effect in patients with acute myocardial infarction

  2011cites this paper
• Indigenous herbal product Nigella sativa proved effective as an Anti-obesity therapy in metabolic syndrome

  2011cites this paper
• Estatinas - transversalidade das suas aplicações clínicas.

  2011cites this paper
• Cyclic nucleotides and mitogen-activated protein kinases: regulation of simvastatin in platelet activation

  2010cites this paper
• A randomised determination of the Effect of Fluvastatin and Atorvastatin on top of dual antiplatelet treatment on platelet aggregation after implantation of coronary drug-eluting stents

  2010cites this paper
• Ausência de Interação Clopidogrel-Estatina em Pacientes Submetidos a Implante de "Stent" Coronariano Lack of Clopidogrel-Statin Interaction in Patients Undergoing Coronary Stent Implantation

  2010cites this paper
• Basic Science Review: Statin Therapy-Part I: The Pleiotropic Effects of Statins in Cardiovascular Disease

  2010cites this paper
• Ausência de interação clopidogrel-estatina em pacientes submetidos a implante de "stent" coronário

  2010cites this paper
• Lack of clopidogrel-statin interaction in patients undergoing coronary stent implantation.

  2010cites this paper
• Modulation of rabbit platelet aggregation and calcium mobilization by platelet cholesterol content.

  2010cites this paper
• Effect of atorvastatin on platelet thromboxane A(2) synthesis in aspirin-treated patients with acute myocardial infarction.

  2009cites this paper
• Longitudinal platelet reactivity to acute psychological stress among older men and women

  2009cites this paper
• Novel approaches for preventing or limiting events (Naples) II trial: impact of a single high loading dose of atorvastatin on periprocedural myocardial infarction.

  2009cites this paper
• Pleiotropic vasoprotective effects of statins: The chicken or the egg?

  2009cites this paper
• Preinjury statin use is associated with a higher risk of multiple organ failure after injury: a propensity score adjusted analysis.

  2009cites this paper
• Review Article: THE 22 PLEIOTROPIC PROPERTIES OF STATIN AND CARDIOVASCULAR DISEASES The Roles of Atorvastatin with Its PPECCAT-GOMMESAAB Effects

  2009cites this paper
• Interactions Between Lipoproteins and Platelet Membranes in Obesity

  2009cites this paper
• Antiplatelet Actions of Statins and Fibrates Are Mediated by PPARs

  2009cites this paper
• A novel reciprocal and biphasic relationship between membrane cholesterol and β‐secretase activity in SH‐SY5Y cells and in human platelets

  2009cites this paper
• Vascular protection with atorvastatin after acute ischemic stroke in diabetes

  2008cites this paper
• Ezetimibe's effect on platelet aggregation and LDL tendency to peroxidation in hypercholesterolaemia as monotherapy or in addition to simvastatin.

  2008cites this paper
• Nouveaux paramètres d'exploration de la fonction plaquettaire en clinique : thrombose tardive, profilage micro-membranaire et détection de sous-populations cellulaires

  2008cites this paper
• The antiplatelet effect of atorvastatin in patients with acute coronary syndrome depends on the hs-CRP level

  2008cites this paper
• Enhanced nitric oxide and cyclic GMP formation plays a role in the anti‐platelet activity of simvastatin

  2008influential citation
• Effect of high dose statin therapy on platelet function; statins reduce aspirin resistant platelet aggregation in patients with coronary heart disease

  2007cites this paper
• Statin Therapy for Secondary Stroke Prevention: Evidence Catches Up to Practice

  2007cites this paper
• Therapeutic Effect Of Nigella Sativa Oil On Different Clinical And Biochemical Parameters In Metabolic Syndrome

  2007cites this paper
• Die Bedeutung der Thrombozytenaktivierung in der Pathogenese und Behandlung kardiologischer Erkrankungen

  2007cites this paper
• The effect of simvastatin on erythrocyte membrane fluidity during oxidative stress induced by cardiopulmonary bypass: a randomized controlled study.

  2007cites this paper
• The role of HMG-CoA reductase inhibition in endothelial dysfunction and inflammation

  2007cites this paper
• High density lipoprotein modulates platelet function

  2006cites this paper
• Coronary artery disease in women: a review on prevention, pathophysiology, diagnosis, and treatment

  2006cites this paper
• Fluvastatin, HMG‐CoA Reductase Inhibitor: Antiatherogenic Profiles Through Its Lipid‐Lowering–Dependent and ‐Independent Actions

  2006cites this paper
• Molecular Defects in the ABCA1 Pathway Affect Platelet Function

  2006cites this paper
• Hypertensive patients with carotid artery plaque exhibit increased platelet aggregability.

  2006cites this paper
• Statin use and survival in patients with chronic heart failure--results from two observational studies with 5200 patients.

  2006cites this paper
• A review of the lipid-related effects of fluvastatin

  2005cites this paper
• Molecular defects in the ABCA1 pathway affect platelet function.

  2005cites this paper
• The influence of antibiotics and statins on inflammation in coronary disease.

  2005cites this paper
• Cholesterol in Alzheimer's disease.

  2005cites this paper
• Pravastatin reduces fibrinogen receptor gpIIIa on platelet‐derived microparticles in patients with type 2 diabetes

  2005cites this paper
• Does the use of statins compromise the effectiveness of platelet inhibition by clopidogrel?

  2004cites this paper
• Chapter 12 – Anticoagulant Effects of Statins

  2004cites this paper
• [Interactions of statins with antithrombotic drugs].

  2004cites this paper
• Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands

  2004cites this paper
• ADP induced platelet degranulation in healthy individuals is reduced by clopidogrel after pretreatment with atorvastatin

  2004cites this paper
• Statin administration before percutaneous coronary intervention: impact on periprocedural myocardial infarction.

  2004cites this paper
• Ocular Hemorrhage Possibly the Result of HMG-CoA Reductase Inhibitors

  2004cites this paper
• Beeinflussen Statine die Effekte antithrombotischer Pharmaka?

  2004cites this paper
• Statin Reduce the Platelet P-Selectin Expression in Atherosclerotic Ischemic Stroke

  2004cites this paper
• Statins in Atherothrombosis

  2004cites this paper
• The Metabolic Syndrome and Inflammation

  2004cites this paper
• Olive oil and haemostasis

  2004cites this paper
• Low-density lipoprotein and its effect on human blood platelets

  2003cites this paper
• Role of in vitro cholesterol depletion in mediating human platelet aggregation

  2003cites this paper
• New insights in platelet signaling by Low Density Lipoprotein

  2003cites this paper
• The Statins: Multifunctional Antithrombotic and Antineoplastic Drugs

  2003cites this paper
• Statins in coronary bypass surgery: rationale and clinical use.

  2003cites this paper
• The lipid and non-lipid effects of statins.

  2003cites this paper
• [Non-lipid effects of statins: myth or fact?].

  2003cites this paper
• Die „Non-Lipid-Effekte“ der Statine: Mythos oder Faktum?

  2003cites this paper
• Early vascular benefits of statin therapy

  2003cites this paper
• Statini u primarnoj i sekundarnoj prevenciji koronarne bolesti

  2003cites this paper
• The effects of lipid-regulating therapy on haemostatic parameters.

  2003cites this paper
• Effects of Statins on Nonlipid Serum Markers Associated with Cardiovascular Disease

  2003cites this paper
• [Markers of inflammation and platelet aggregation in patients with non ST elevation acute coronary syndrome treated with atorvastatin or pravastatin].

  2003cites this paper
• Pravastatin inhibits pro-inflammatory effects of Alzheimer's peptide Abeta(1-42) in glioma cell culture in vitro.

  2003cites this paper
• The statins: multifunctional antithrombotic and antineoplastic drugs.

  2003cites this paper
• Relation of markers of inflammation (C-reactive protein, fibrinogen, von Willebrand factor, and leukocyte count) and statin therapy to long-term mortality in patients with angiographically proven coronary artery disease.

  2002cites this paper
• Influence of HMG-CoA reductase inhibitors on markers of coagulation, systemic inflammation and soluble cell adhesion.

  2002cites this paper
• Time‐dependent effect of statins on platelet function in hypercholesterolaemia

  2002cites this paper
• Non Lipid Related Effects of Statins

  2002cites this paper
• Cholesterol-induced Thrombogenicity of the Vessel Wall: Inhibitory Effect of Fluvastatin

  2002cites this paper
• Fluvastatin reduces modification of low-density lipoprotein in hyperlipidemic rabbit loaded with oxidative stress.

  2002cites this paper
• Treatment with Cerivastatin in Primary Mixed Hyperlipidemia Induces Changes in Platelet Aggregation and Coagulation System Components

  2002cites this paper
• HMG-CoA Reductase Inhibition in the Treatment of Atherosclerosis: Effects Beyond Lipid Lowering

  2002cites this paper